The present compounds may be useful to develop potent lead compounds for the treatment of diabetes through promoting the adiponectin secretion and tyrosine phosphorylation of insulin receptor-β and GLUT4 translocation. The gene discussed is SLC2A4; the disease is diabetes mellitus.